Paul Brunetta
University of California, San Francisco(US)Sana Biotechnology (United States)(US)
Publications by Year
Research Areas
Systemic Lupus Erythematosus Research, Vasculitis and related conditions, Renal Diseases and Glomerulopathies, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis(2010)2,684 cited
- → Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study(2012)1,404 cited
- → Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial(2009)1,365 cited
- → Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis(2013)721 cited
- → B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial(2022)404 cited
- → Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double‐Blind, Phase III Study(2013)348 cited